Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2007

01-08-2007

Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia

Authors: M. Kourti, N. Vavatsi, N. Gombakis, V. Sidi, G. Tzimagiorgis, T. Papageorgiou, D. Koliouskas, F. Athanassiadou

Published in: International Journal of Hematology | Issue 2/2007

Login to get access
Metadata
Title
Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia
Authors
M. Kourti
N. Vavatsi
N. Gombakis
V. Sidi
G. Tzimagiorgis
T. Papageorgiou
D. Koliouskas
F. Athanassiadou
Publication date
01-08-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.E0624

Other articles of this Issue 2/2007

International Journal of Hematology 2/2007 Go to the issue

OriginalPaper

Therapy with Bortezomib plus Dexamethasone Induces Osteoblast Activation in Responsive Patients with Multiple Myeloma

OriginalPaper

L-Arginine Administration Reverses Anemia Associated with Renal Disease

Letter to the Editor

Molecular Cloning of Translocation Breakpoint from der(8)t(3;8)(q27;q24) Defines Juxtaposition of Downstream ofC-MYC and Upstream of BCL6

OriginalPaper

Analysis of NPM1 Gene Mutations in Chinese Adults with Acute Myeloid Leukemia

Case Report

Donor Cell-Derived Chronic Myeloproliferative Disease with t(7;11)(p15;p15) after Cord Blood Transplantation in a Patient with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Progress in Hematology

Implication of the HTLV- I bZIP Factor Gene in the Leukemogenesis of Adult T-Cell Leukemia

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits